Chicago Zantac Cancer Lawsuit Attorney

Everything You Need To Know About The Zantac Recall

Zantac is a brand-name form of ranitidine, which is an H2 blocker that’s used to treat heartburn, ulcers, gastroesophageal reflux disease (GERD), and similar ailments. For years it has been a popular over-the-counter medication that many people used to find regular relief from these common health afflictions. Zantac was recently recalled because of traces of a known cancer causing substance called NDMA being found in the drug.

If you have taken Zantac and been diagnosed with any form of cancer, we strongly advise you to speak with an attorneyabout the potential for you to have a legal case that could entitle you to compensation.

Zantac Product Removal From The Market

Recently, Zantac and other drugs containing the compound ranitidine have recently been linked to various forms of cancer. As a result, the Food and Drug Administration (FDA) recently called for all Zantac and other ranitidine products to immediately be pulled from the market. Last year, several major drugstore chains stopped selling these drugs, and one such chain even offered refunds for recent purchases. All these extraordinary measures are based on the FDA’s detection of NDMA – a known carcinogen – in Zantac and other ranitidine products.
NDMA – A Dangerous Contaminant Detected in Zantac

N-Nitrosodimethylamine, or NDMA, is a contaminant that both the World Health Organization (WHO) and the International Agency of Research on Cancer (IARC) identify as a probable carcinogen. Exposure to high doses of NDMA is closely associated with colorectal and other cancers. Further, NDMA is extremely toxic to the liver and, even in small doses, may cause liver damage.

Details About The FDA Withdrawal of Zantac

In April of 2020, the FDA actually issued a market withdrawal of Zantac, which does not rise to the level of an FDA recall. The distinction – according to the FDA – is as follows:

  • A Market Withdrawal is based on a minor violation of the FDA’s laws and is not subject to legal action by the Administration.
  • A Recall, on the other hand, is a removal or a correction of a marketed consumer product that the FDA deems in violation of its laws.

Speak with a Chicago Zantac Cancer Lawsuit Attorney Today

If you have taken Zantac and been diagnosed with any form of cancer in addition to the ones listed on this page, it is critical that you speak with an attorney who is knowledgeable and experienced in fighting lawsuits like this against large corporations.

At Malman Law, we have paralegals available 24/7 to take your call and help examine your case.

Details Regarding the Zantac Recall

  • The U.S. Food and Drug Administration announced on April 1, 2020 that it is requesting manufacturers to withdraw all Zantac and generic Zantac OTC ranitidine drugs from the market effective immediately because of traces of NDMA being found in Zantac.
  • The FDA, the Environmental Protection Agency (EPA) classify NDMA (also knowns N-nitrosodimethylamine) as a probable carcinogen and cancer-causing substance.
  • The following cancers are linked to Zantac and its generic form: Stomach, Bladder, Kidney, Pancreatic, Liver, Breast, Testicular or Colon Cancer after Taking Brand Name Prescription or Over the Counter Zantac (Ranitidine).

Reasons you may be entitled to compensation

If you live in Chicago (or anywhere in Illinois) and have been taking Zantac, there are several potential medical conditions that may entitle you to financial compensation.

The following is a non-exhaustive list of potential medical issues that Zantac may have caused that may entitle you to compensation:

What’s your case worth? Submit for a free case review

Our Location


205 W. Randolph St., #1700,
Chicago, IL 60606

Malman Library Resources

Know Your Rights!